NYSE:BAC

Bank of America (BAC)

50.56
-0.52 (1.02%)
as of Oct 23, 2026, 8:00:00 pm Market Closed.
708 watching
0
BUY

Is not effected by tariffs, unless tariffs impact the broader economy strongly. BAC reports tomorrow and he expects good numbers. (Bank earnings today sees improving net interest income, which bodes well for BAC.)

BUY

It reports Wednesday. Trades at only 13x PE, cheap because of the relentless selling by Berkshire Hathaway. But when that selling stops, the PE will be much higher. He expects a good quarter.

BUY

Trades at 1.25x book value and almost a 3% dividend yield. Are growing revenues and increasing market share. Will benefit from IPOs and M&A. Wealth management generates recurring revenues. They keep costs low.

BUY

Keep a full weighting in the financial sector, which is primed for doing well in the next leg of the market. The sector is not expensive and has policy tailwinds. Banks are best capitalized in their history. It's a red herring--don't be scared off by Trump's Big, Beautiful Bill (and the fear of higher taxes).

BUY

The US banks are cheap in valuation, and benefit from an M&A cycle that will come.

BUY

High quality. Globalization is starting to move in a different direction, so this option provides a more domestic focus.

TOP PICK

Stock's fallen a fair bit, which was unexpected given the numbers reported last week. Lots of capital; lots of room to increase dividend and buy back shares. Environment is tough with potential recession. Trading at 1x book, 10x PE. Some of the best businesses in the world -- asset management, financial services, capital markets (one of the top 4 players globally), retail, credit cards. Yield is 2.74%.

(Analysts’ price target is $48.46)
DON'T BUY
BAC vs. TD

Likes TD a lot. Very undervalued at 10x PE. Potential for multiple to rerate in medium term. More upside as it distances itself from the overhang of regulatory infractions. All that should give you a better total return. He'd pick TD.

For BAC, even with deregulation in US, the big banks are already so large, it's hard to imagine they'd be allowed to get even bigger.

DON'T BUY

He'd rather an investor look at JPM. JPM has a rock-solid balance sheet, and probably the best technology platform and management.

BUY

Financial sector offers great promise, though it's reacted to current markets by pricing in a potential recession. Slower economic growth would not be good for banks. Absent a recession, with consumer confidence returning and unleashing M&A, the sector provides a good opportunity.

A less expensive choice further down the food chain from the likes of JPM.

PAST TOP PICK
(A Top Pick Apr 17/24, Down 3%)

Still positive on financial sector and on money centre banks in particular. Yield curve is starting to normalize, a positive for banks. 

HOLD

If the US consumer struggles and can't buy goods and job losses rise due to tariffs, this will slow down the economy and directly impact banks like BAC. It's hard to know where tariffs are going. The dividend is high and BAC has a good, long track record. Best to collect the dividend and wait.

BUY

Likes US financials. Quietly up ~49% last 12 months. Just watch that's it's coming up to potential resistance around $50, which it hit in early 2022. If it breaks above, great sign; but might also bounce down below it. He owns GS. 

See his Top Picks.

TOP PICK

Loves the money-centre banks. Not quite as expensive as JPM, but more interest-rate sensitive. A gently falling interest-rate environment (which he thinks will come to pass, though it's up for debate), net interest margins will widen and that's traditionally good for banks. Capital markets business has really built up, and will open up post-Biden. Economy in pretty good shape. Undemanding valuation. Yield is 2.3%.

(Analysts’ price target is $52.46)
BUY

Very good company with excellent prospects. Owns shares in the company. Believes banking stocks will continue to lead market. Deregulation from President Trump will allow company to generate new profits. New Crypto developments will also provide catalysts for growth. 

Showing 31 to 45 of 1,348 entries